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The article by Johns et al. (1) compares the Hopkins Symptom
Checklist 20-item depression scale (HSCL-20) (2), the
Short-Form 36 Mental Health Inventory five-item distress
scale (MHI-5) (3), and the Patient Health Questionnaire
nine-item depression scale (PHQ-9) (4) in 309 adults
with cancer in a longitudinal study. The authors compare
internal consistencies and construct validity. Moreover, they
address responsiveness of these three scales to results of a
systematic treatment of depression over three-months by
comparing these measures to patients’ self-reports of their
depressive symptoms (improved, no change, or worsening).
These comparisons provide clinically relevant information
considering the fact that studies find comorbidity of cancer
with depression ranging from 3-77% with especially
high numbers in patients receiving palliative care (for
a review see) (5). As Vodermaier et al. (6) point out, the
wide range of prevalence rates can be partially explained
by differences in diagnostic criteria and instruments
used to measure depression. Taking this into account
and considering the significant negative consequences
of depression (including but not limited to functional
impairment, reduced quality of life, poor treatment
adherence, and even increased mortality; for reviews see)
(6-8), Johns et al.’s (1) focus on patient-reports of depression
with good psychometrics address an important topic.
Johns et al. (1) report good internal consistencies and
construct validity at baseline for all three scales. Looking
into responsiveness, John et al. (1) confirm that all three
instruments differentiate between patients reporting their
depression as improved, unchanged, or worse after three
months of systematic treatment and each of these measures
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is able to depict a treatment effect when compared to a
control group. Finally, using receiver operating curve
analysis the scales distinguish improved from non-improved
patients. In summarizing, this study is indicating the HSCL20 (2), the MHI-5 (3), and the PHQ-9 (4) to be appropriate
measures to assess depressive symptoms in adult cancer
patients based on their psychometric values. From a clinical
point of view, this is an encouraging result, as all three
measures are short and therefore easily utilized in a patient
population oftentimes challenged by limited attention span
and fatigue (9). Moreover, the straightforward scoring
options for each of the scales increase the likelihood of their
application in busy clinical settings.
One other interesting finding that Johns et al. (1) report
is that two abbreviated versions of the studied instruments
(MHI-d and PHQ-2) show less responsiveness to changes
in depression when compared to the full length instruments
(HSCL-20, MHI-5, PHQ-9). Johns et al. (1) use this pattern
of findings to engage in the debate whether depression
instruments that contain somatic items overestimate the
associations between depression and cancer [e.g., (7,10-14)].
This discussion is fueled by the fact that the DSM-IV
relies heavily on somatic symptoms for the diagnosis of a
depressive disorder and these symptoms are seen commonly
in cancer patients as result of their illness progression or
as adverse effects of their treatments (e.g., fatigue, poor
appetite, sleep problems). Therefore, the interpretation
of somatic symptoms has been labeled as one of the
most common problems in diagnosing depression in
cancer patients (15). However, Johns et al. (1) argue their
findings that instruments including somatic items show
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more responsiveness to demonstrate that somatic items
do not lead to an overestimation of depression in cancer
patients. Nevertheless, such interpretations need to be
made cautiously as change in depression is only assessed by
patient-responses to the retrospective question, ‘‘Overall,
since starting the study, would you say that your depression
is worse, about the same, or better?’’. It might be that
patients include their overall well-being and physical
symptoms into their own depression evaluation as they are
not given any criteria on how to assess their depression.
This may be particularly true as patients have been asked
this question after repeatedly filling in the questionnaires
(including somatic symptoms) that might shape their
impression of how the researchers define depression.
Therefore, the patient report may at least in part be based
on symptoms related to the patient’s cancer or treatment
side effects rather than their depression. In line with this
topic, a recent meta-analysis about depression as predictor
of the development of breast cancer found that studies
using depression instruments including somatic items
found stronger associations between cancer and depression
than studies that do not assess these symptoms (16). This
underscores the need for future research to clarify this issue
further.
In conclusion, Johns et al.’s (1) study is set apart from
other attempts to evaluate depression scales by taking the
extra effort to utilize a longitudinal design. Moreover,
including three measures in their research design allows
for comprehensive discussions. Given these advantages,
it would have been desirable to include instruments with
widespread clinical utilization like the Hospital Anxiety
and Depression Scale (HADS) (17), even if they have been
researched in cross-sectional designs before. Considering
that the HADS is one of the most often utilized instruments
to measure depression in cancer patients (8) and the fact
that recent reviews of depression instruments come to the
conclusion that the HADS is one of the best instrument for
assessing depression in cancer patients (6-8), the inclusion of
the HADS would allow to compare the findings regarding
the HSCL, MHI, and PHQ to this “gold standard” of
patient-reports in cancer patients.
Depression is one of the most common mental health
problems in palliative care (18) but current literature
still reports concerning underdiagnosing of depressive
disorders in this patient population (19,20). Efforts
to provide psychometrically sound tools to assess for
depressive symptoms are one important step to address this
challenge. As many settings still do not have mental health
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professionals readily available to routinely assess all cancer
patients (9), future research is needed to focus on how
these assessment tools can be used by other professionals
(e.g., nurses) to screen for emotional distress in general
and depressive symptoms in particular to trigger referrals
to specialized professionals who are qualified to diagnose
depressive disorders.
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